Kings Point Capital Management’s AbbVie ABBV Stock Holding History

Kings Point Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.72M	Buy	10,609 +2,550	+32%	+$370K	0.15%	83
2021 Q4	$1.09M	Buy	8,059 +621	+8%	+$73.4K	0.09%	104
2021 Q3	$802K	Buy	7,438 +655	+10%	+$74.8K	0.07%	117
2021 Q2	$764K	Buy	6,783 +634	+10%	+$71.4K	0.07%	123
2021 Q1	$665K	Sell	6,149 -2,851	-32%	-$305K	0.07%	124
2020 Q4	$964K	Sell	9,000 -33	-0.4%	-$3.17K	0.1%	107
2020 Q3	$791K	Buy	9,033 +3,464	+62%	+$326K	0.1%	106
2020 Q2	$547K	Buy	5,569 +3,100	+126%	+$273K	0.08%	114
2020 Q1	$188K	Buy	2,469 +525	+27%	+$44.7K	0.03%	164
2019 Q4	$172K	Hold	1,944	–	–	0.03%	188
2019 Q3	$147K	Buy	1,944 +144	+8%	+$9.87K	0.02%	182
2019 Q2	$131K	Hold	1,800	–	–	0.02%	176
2019 Q1	$145K	Buy	1,800 +1,000	+125%	+$81.8K	0.03%	147
2018 Q4	$74K	Buy	+800	New	+$70.4K	0.02%	183
2017 Q4	–	Sell	-288	Closed	-$26K	–	370
2017 Q3	$26K	Buy	+288	New	+$21.9K	0.01%	272
2016 Q1	–	Sell	-885	Closed	-$52K	–	319
2015 Q4	$52K	Hold	885	–	–	0.01%	194
2015 Q3	$48K	Sell	885 -15	-2%	-$976	0.01%	215
2015 Q2	$60K	Buy	900 +400	+80%	+$26.1K	0.01%	197
2015 Q1	$29K	Hold	500	–	–	0.01%	264
2014 Q4	$33K	Hold	500	–	–	0.01%	242
2014 Q3	$29K	Hold	500	–	–	0.01%	226
2014 Q2	$28K	Hold	500	–	–	0.01%	225
2014 Q1	$26K	Hold	500	–	–	0.01%	210
2013 Q4	$26K	Buy	+500	New	+$24.6K	0.01%	207

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Kings Point Capital Management's ABBV Position: Q1 2022 in Review

Kings Point Capital Management increased its AbbVie (ABBV) stake by 32% in Q1 2022, buying an estimated $370K and bringing the position to 10,609 shares worth $1.72M. The position accounts for 0.15% of the portfolio, ranked #83.

Kings Point Capital Management first reported a position in ABBV in Q4 2013 and has held it in 24 quarters since. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

Kings Point Capital Management held 10,609 shares of AbbVie worth $1.72M as of Q1 2022.
Kings Point Capital Management bought 2,550 AbbVie shares in Q1 2022, an estimated $370K.
AbbVie made up 0.15% of Kings Point Capital Management's portfolio in Q1 2022, its #83 holding.
Kings Point Capital Management first reported a position in AbbVie in Q4 2013 and has held it in 24 quarters since.
3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.